Amgen’s Lumykras gains MHRA approval under Project Orbis
Amgen’s first-in-class medicine Lumykras (sotorasib) has become the first new cancer therapy to receive Conditional Marketing Authorisation for use1 across England, Scotland and Wales...
Government plans revealed to reform adult social care and recover NHS
The Prime Minister has set out plans to tackle the Covid backlogs, reform adult social care, and bring the health and social care system closer together...
NICE backs Janssen’s apalutamide for treatment of prostate cancer
The National Institute of Health and Care Excellence (NICE) has reconsidered its previous decision for Janssen’s Erleada®▼ (apalutamide) and published two positive Final Appraisal...
NHS receives extra £5.4 billion to support COVID-19 response over next 6 months
The Prime Minister and Health and Social Care Secretary Sajid Javid have announced that the NHS will receive an extra £5.4 billion over the...
NICE recommends Novartis’ secukinumab for children with moderate to severe psoriasis
The National Institute for Health and Care Excellence (NICE) has recommended Novartis’ Cosentyx® (secukinumab) as an option for treating moderate to severe plaque psoriasis...
JCVI issues advice on third dose COVID-19 vaccination for severely immunosuppressed
The Joint Committee on Vaccination and Immunisation (JCVI) is advising that people with severely weakened immune systems should have a third vaccine dose as...
NICE and Cochrane collaborate on ‘living’ recommendations for NHS and patients
The National Institute for Health and Care Excellence (NICE) and Cochrane have signed a collaborative agreement which will help to deliver ‘living’ recommendations across...
World-first agreement between Novartis and NHS for cholesterol drug
Novartis has reached a commercial agreement with the NHS in England, enabling broad and rapid access to the cholesterol-lowering medicine Leqvio®▼(inclisiran). The collaboration pioneers...
New GSK shingles vaccine available in UK
GlaxoSmithKline (GSK) has announced that Shingrix, a vaccine to help protect adults against shingles, is now available in the United Kingdom. The vaccine is licensed...
MHRA approval for Astellas’ roxadustat for anaemia of chronic kidney disease
The Medicines and Healthcare products Regulatory Agency (MHRA) has licensed Astellas’ Evrenzo™▼ (roxadustat) for the treatment of adult patients with symptomatic anaemia associated with...
Latest articles
PM Society Digital Awards Winners 2021
Winners from the 12th PM Society Digital Awards have been announced after the event was held online for the second year in a row,...
New patient coalition launched for digital health technology
A new coalition with members from Royal Colleges, health charities and patient groups has come together to ensure the interests of patients are at the...
How to digitalise MSL teams for increased efficiency
Medical Science Liaison (MSL) teams in the pharma industry were already at the limit pre-Covid. Products were complex, wider engagement from healthcare professionals (HCPs)...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
New patient coalition launched for digital health technology
A new coalition with members from Royal Colleges, health charities and patient groups has come together to ensure the interests of patients are at the...
PM Society Digital Awards Winners 2021
Winners from the 12th PM Society Digital Awards have been announced after the event was held online for the second year in a row,...
Sandoz in commercial agreement with Bio-Thera Solutions for biosimilar bevacizumab
Sandoz, a Novartis division, has strengthened its pipeline by entering into a commercialization agreement with Bio-Thera Solutions, Ltd. for biosimilar bevacizumab (BAT1706) for the...
How to digitalise MSL teams for increased efficiency
Medical Science Liaison (MSL) teams in the pharma industry were already at the limit pre-Covid. Products were complex, wider engagement from healthcare professionals (HCPs)...